Preclinical development of HIvax: Human survivin highly immunogenic vaccines
about
Survivin: a unique target for tumor therapyLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesTowards the knowledge-based design of universal influenza epitope ensemble vaccines.Malignant Mesothelioma: Time to Translate?Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.8th vaccine renaissance: A creative nexus for vaccine developers.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.
P2860
Q26747332-EEB7A2A6-7E0B-4EE7-846C-BC61BFC4C1B1Q28395597-DA54DB1C-F597-4601-9ED2-3A40DEEE96F0Q37365222-59044632-D4D4-488B-ADFA-77C2F22C286EQ39366003-FBDAF34D-1E0D-44FF-9593-120622BE698EQ40042419-FA2519AE-58E0-4003-85EC-9CFF91218CD2Q43185264-4A78FE8A-E7D0-4665-B81D-ADB5AE905E45Q52672878-84089911-A36C-4086-927D-4D21A4D352B6
P2860
Preclinical development of HIvax: Human survivin highly immunogenic vaccines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preclinical development of HIvax: Human survivin highly immunogenic vaccines
@en
type
label
Preclinical development of HIvax: Human survivin highly immunogenic vaccines
@en
prefLabel
Preclinical development of HIvax: Human survivin highly immunogenic vaccines
@en
P2093
P2860
P50
P1476
Preclinical development of HIvax: Human survivin highly immunogenic vaccines
@en
P2093
Aaron H Rose
Antonio Siccardi
Elisa Soprana
Frances Terry
Fukun W Hoffmann
Giovanni Gaudino
Ivo Sah Bandar
Maddalena Panigada
Mahdi Belcaid
Michele Carbone
P2860
P304
P356
10.1080/21645515.2015.1050572
P577
2015-01-01T00:00:00Z